EvidenceCLimitedStudies in people with real weaknesses: small, short or conflicting trials, or observational studies only.
Omega-3 supplements have not clearly slowed cognitive decline. The largest trial found no effect over 3 years, while smaller, shorter trials show small memory gains in some healthy older adults.
Who it's for
Healthy older adults, possibly; not shown to help people with dementia.
What to expect
No clear slowing of decline; small memory test gains in some trials.
Watch out for
Mild side effects like bad taste and stomach upset; very high doses may thin blood.
Omega-3 pills showed little effect on memory in trials
Each dot is an average effect with a line for its likely range; a line crossing zero means no clear effect.
← WorseBetter →
No difference
Composite memory, all people0.04 (−0.06 to 0.14)No clear difference
Immediate recall, all people0.04 (−0.05 to 0.13)No clear difference
Immediate recall, mild impairment0.16 (0.01 to 0.31)Probably better
Attention and speed, mild impairment0.3 (0.02 to 0.57)Probably better
00.20.40.6
effect size, 0 = no difference
Omega-3 pills showed little effect on memory in trials
The NIH Office of Dietary Supplements sets no upper limit for omega-3s, but notes that high doses may weaken immune responses and, at 2 to 15 g a day, lengthen bleeding time11Guideline · 2026Omega-3 Fatty Acids: Fact Sheet for Health ProfessionalsThe IOM did not establish a UL for any omega-3s, although it noted that high doses of DHA and/or EPA (900 mg/day of EPA plus 600 mg/day DHA or more for several weeks) might reduce immune function due to suppression of inflammatory responses. Doses of 2–15 g/day EPA and/or DHA might also increase bleeding time by red…NIH Office of Dietary Supplements. It does not recommend omega-3s for cognitive decline in the passages reviewed.
What the studies show
The largest trial randomized 1,680 adults aged 70 or older with memory complaints. Omega-3 capsules for 3 years made no significant difference in cognitive decline compared with a dummy pill (placebo A dummy treatment that looks like the real one, so people can't tell which they got.)2Randomized trial · 2017 · 1,680 peopleEffect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.The multidomain intervention and polyunsaturated fatty acids, either alone or in combination, had no significant effects on cognitive decline over 3 years in elderly people with memory complaints. An effective multidomain intervention strategy to prevent or delay cognitive impairment and the target population remain…Lancet Neurol.
A review that pooled 10 older trials (934 people) found no effect on memory overall. A small gain appeared in people with mild thinking problems, and none in healthy people or those with Alzheimer's disease10Meta-analysis · 2012 · 934 peopleEffects of ω-3 fatty acids on cognitive performance: a meta-analysis.These results suggest an effect of n-3 FAs within specific cognitive domains in CIND, but not in healthy or AD subjects.Neurobiol Aging.
A review that pooled 24 trials (9,660 people, 3 to 36 months) found a trend toward better executive function (planning and mental flexibility) in the first 12 months. This was seen at daily doses above 500 mg, and more in people whose blood omega-3 was not very low3Meta-analysis · 2024The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.Supplementation of n-3 PUFA may confer potential benefits to executive function among the middle-aged and elderly demographic, particularly in individuals whose dietary DHA + EPA level is not substantially diminished.BMC Med.
Smaller trials found gains on some tests. DHA at 900 mg a day for 24 weeks in 485 adults with age-related memory decline reduced errors on a learning test6Randomized trial · 2010 · 485 peopleBeneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.Twenty-four week supplementation with 900 mg/d DHA improved learning and memory function in ARCD and is a beneficial supplement that supports cognitive health with aging.Alzheimers Dement. A trial of 44 adults found better recall of object locations with 2,200 mg a day for 26 weeks9Randomized trial · 2016 · 22 peopleImpact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.This double-blind placebo-controlled proof-of-concept study provides further experimental evidence that LC-n3-FA exert positive effects on memory functions in healthy older adults. Our findings suggest novel strategies to maintain cognitive functions into old age.J Alzheimers Dis. These tests measure memory at one point, not decline over time.
A trial of 163 people with mild cognitive impairment or Alzheimer's found no significant change in thinking, daily function or mood after 24 months on DHA, EPA or both7Randomized trial · 2022 · 42 peopleOmega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.Overall, n-3 PUFAs supplements did not reduce cognitive, functional, and depressive symptom outcomes, but spoken language ability and constructional praxis subitems of ADAS-cog. These findings show that attention to clinical heterogeneity in dementia is crucial when studying nutrients interventions, such as n-3 PUFAs.…Brain Behav Immun.
Studies that followed people over time link higher omega-3 intake to about 20% lower risk of dementia or cognitive decline1Meta-analysis · 2023 · 103,651 peopleThe Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.4%) were associated with a lower risk of cognitive decline. Dietary intake or long-term supplementation of omega-3 fatty acids may help reduce risk of AD or cognitive decline.Am J Clin Nutr. These are associations, and people who eat more fish may differ in other ways. Such figures compare groups, so one person's gain depends on their starting risk.
Key studies
Study
Who
What it found
Trial, 20172Randomized trial · 2017 · 1,680 peopleEffect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.The multidomain intervention and polyunsaturated fatty acids, either alone or in combination, had no significant effects on cognitive decline over 3 years in elderly people with memory complaints. An effective multidomain intervention strategy to prevent or delay cognitive impairment and the target population remain…Lancet Neurol
1,680 adults 70+, memory complaints
No significant effect on 3-year decline
Review of 10 trials, 201210Meta-analysis · 2012 · 934 peopleEffects of ω-3 fatty acids on cognitive performance: a meta-analysis.These results suggest an effect of n-3 FAs within specific cognitive domains in CIND, but not in healthy or AD subjects.Neurobiol Aging
934 healthy, impaired or Alzheimer's
No memory benefit overall
Review of 24 trials, 20243Meta-analysis · 2024The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.Supplementation of n-3 PUFA may confer potential benefits to executive function among the middle-aged and elderly demographic, particularly in individuals whose dietary DHA + EPA level is not substantially diminished.BMC Med
9,660 adults 40+ without dementia
Possible executive function gain in first year
Trial, 20106Randomized trial · 2010 · 485 peopleBeneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.Twenty-four week supplementation with 900 mg/d DHA improved learning and memory function in ARCD and is a beneficial supplement that supports cognitive health with aging.Alzheimers Dement
485 older adults with memory decline
Fewer errors on one learning test at 24 weeks
Review of 48 studies, 20231Meta-analysis · 2023 · 103,651 peopleThe Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.4%) were associated with a lower risk of cognitive decline. Dietary intake or long-term supplementation of omega-3 fatty acids may help reduce risk of AD or cognitive decline.Am J Clin Nutr
103,651 people followed over time
About 20% lower dementia or decline risk, linked to intake
Safety
Side effects are usually mild: unpleasant taste, bad breath, heartburn, nausea, diarrhea, headache11Guideline · 2026Omega-3 Fatty Acids: Fact Sheet for Health ProfessionalsThe IOM did not establish a UL for any omega-3s, although it noted that high doses of DHA and/or EPA (900 mg/day of EPA plus 600 mg/day DHA or more for several weeks) might reduce immune function due to suppression of inflammatory responses. Doses of 2–15 g/day EPA and/or DHA might also increase bleeding time by red…NIH Office of Dietary Supplements. In the large trial, serious side effects were similar across groups2Randomized trial · 2017 · 1,680 peopleEffect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.The multidomain intervention and polyunsaturated fatty acids, either alone or in combination, had no significant effects on cognitive decline over 3 years in elderly people with memory complaints. An effective multidomain intervention strategy to prevent or delay cognitive impairment and the target population remain…Lancet Neurol. Doses of 2 to 15 g a day of EPA and DHA might lengthen bleeding time11Guideline · 2026Omega-3 Fatty Acids: Fact Sheet for Health ProfessionalsThe IOM did not establish a UL for any omega-3s, although it noted that high doses of DHA and/or EPA (900 mg/day of EPA plus 600 mg/day DHA or more for several weeks) might reduce immune function due to suppression of inflammatory responses. Doses of 2–15 g/day EPA and/or DHA might also increase bleeding time by red…NIH Office of Dietary Supplements.
What we don't know
Whether omega-3s slow decline over many years in healthy people. Two large trials of this question have been completed12Registered trial · 2011A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive DeclineClinicalTrials.gov,13Registered trial · 2007DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's DiseaseClinicalTrials.gov, and another is under way14Registered trial · 2024Optimizing CNS DHA Delivery in Elderly Adults at Risk for DementiaClinicalTrials.gov.
Which dose, type (DHA or EPA) and which people, such as those with low fish intake, might benefit.
Written by AI from the studies listed, without review by a clinician, and graded with the GRADE method. It can be wrong, so check the studies it cites. Education, not medical advice.